Discussions on VT4COVID

Affiliations

¹ Department of Respiratory Medicine, Ghent University Hospital, Ghent B-9000, Belgium. Electronic address: jan.demey@UGent.be.
² Department of Intensive Care, Ghent University Hospital, Ghent B-9000, Belgium.

Comment

Jan De Mey et al. Lancet Respir Med. 2023 Nov.

. 2023 Nov;11(11):e90.

doi: 10.1016/S2213-2600(23)00342-9.

¹ Department of Respiratory Medicine, Ghent University Hospital, Ghent B-9000, Belgium. Electronic address: jan.demey@UGent.be.
² Department of Intensive Care, Ghent University Hospital, Ghent B-9000, Belgium.

No abstract available

Conflict of interest statement

We declare no competing interests.

Discussions on VT4COVID - Authors' reply.
Richard JC, Rabilloud M, Chorfa F, Bitker L. Richard JC, et al. Lancet Respir Med. 2023 Nov;11(11):e91-e92. doi: 10.1016/S2213-2600(23)00344-2. Lancet Respir Med. 2023. PMID: 37914472 No abstract available.

Ultra-low tidal volume ventilation for COVID-19-related ARDS in France (VT4COVID): a multicentre, open-label, parallel-group, randomised trial.
Richard JC, Terzi N, Yonis H, Chorfa F, Wallet F, Dupuis C, Argaud L, Delannoy B, Thiery G, Pommier C, Abraham P, Muller M, Sigaud F, Rigault G, Joffredo E, Mezidi M, Souweine B, Baboi L, Serrier H, Rabilloud M, Bitker L; VT4COVID collaborators. Richard JC, et al. Lancet Respir Med. 2023 Nov;11(11):991-1002. doi: 10.1016/S2213-2600(23)00221-7. Epub 2023 Jul 12. Lancet Respir Med. 2023. PMID: 37453445 Clinical Trial.